Skip to main content


Figure 8 | Molecular Cancer

Figure 8

From: Characterisation and manipulation of docetaxel resistant prostate cancer cell lines

Figure 8

NF-κB inhibitor studies following docetaxel treatment. The PC-3 sublines where pre-treated with the NFκB inhibitor (BAY 11-7082, 5 μM) for 24 hours followed by Docetaxel (20 nM) for a further 48 hours and assessed for apoptosis by flow cytometry. Graphs represent the results of 3 independent experiments. Mean values were compared using t-test assuming equal variances. * p < 0.05.

Back to article page